Optimal timing and drug combination of selinexor in multiple myeloma: a systematic review and meta-analysis
ABSTRACTObjectives Multiple myeloma (MM) remains an incurable disease despite advances in treatment options. Recently, selinexor has shown promising efficacy for relapsed/refractory multiple myeloma (RRMM), whereas its optimal timing and drug combination remain unclear. In order to assess the variou...
Zapisane w:
| Główni autorzy: | , , , , , |
|---|---|
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
Taylor & Francis Group
2023-12-01
|
| Seria: | Hematology |
| Hasła przedmiotowe: | |
| Dostęp online: | https://www.tandfonline.com/doi/10.1080/16078454.2023.2187972 |
| Etykiety: |
Nie ma etykietki, Dołącz pierwszą etykiete!
|